A Study of Treatment Success in Changing From Olanzapine to Long-acting Injectable Risperidone (RISPERDAL® CONSTA™)
Clinical trial NCT00216632 · COMPLETED
Trial details
- NCT number
- NCT00216632
- Sponsor
- Janssen Pharmaceutica N.V., Belgium
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2005-03-01
- Primary completion
- 2007-07-01
- Enrollment
- 99
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.